Literature DB >> 16436736

Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.

Katsuhiko Hayashi1, Shin-etsu Kadowaki, Masaya Takei, Hideyuki Fukuda.   

Abstract

We established a mouse model of secondary pneumococcal pneumonia after influenza virus infection and investigated the efficacy of several quinolones against pneumonia in this model. Gatifloxacin exhibited the highest efficacy among the quinolones examined and is probably useful for the treatment of secondary bacterial pneumonia.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16436736      PMCID： PMC1366889          DOI： 10.1128/AAC.50.2.748-751.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Deaths: final data for 2001.

Authors:  Elizabeth Arias; Robert N Anderson; Hsiang-Ching Kung; Sherry L Murphy; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2003-09-18

2.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza.

Authors:  D B LOURIA; H L BLUMENFELD; J T ELLIS; E D KILBOURNE; D E ROGERS
Journal:  J Clin Invest       Date:  1959-01       Impact factor: 14.808

3.  Impact of epidemic type A influenza in a defined adult population.

Authors:  W H Barker; J P Mullooly
Journal:  Am J Epidemiol       Date:  1980-12       Impact factor: 4.897

4.  Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae.

Authors:  Ronald N Jones; David R Andes; Lionel A Mandell; Samantha Gothelf; Anton F Ehrhardt; Susan C Nicholson
Journal:  Diagn Microbiol Infect Dis       Date:  2002-09       Impact factor: 2.803

5.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

6.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.

Authors:  Jonathan A McCullers
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

7.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

8.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

9.  Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice.

Authors:  Shigefumi Okamoto; Shigetada Kawabata; Ichiro Nakagawa; Yoshinobu Okuno; Toshiyuki Goto; Kouichi Sano; Shigeyuki Hamada
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 10.  [Clinical features of pneumonia associated with influenza virus infection].

Authors:  Jiro Fujita
Journal:  Nihon Rinsho       Date:  2003-11
View more
  5 in total

1.  High-Throughput Screening Assay to Identify Small Molecule Inhibitors of Marburg Virus VP40 Protein.

Authors:  Priya Luthra; Manu Anantpadma; Sampriti De; Julien Sourimant; Robert A Davey; Richard K Plemper; Christopher F Basler
Journal:  ACS Infect Dis       Date:  2020-09-16       Impact factor: 5.084

2.  Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury.

Authors:  Yuki Enoki; Yu Ishima; Ryota Tanaka; Keizo Sato; Kazuhiko Kimachi; Tatsuya Shirai; Hiroshi Watanabe; Victor T G Chuang; Yukio Fujiwara; Motohiro Takeya; Masaki Otagiri; Toru Maruyama
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 3.  Animal models for the study of influenza pathogenesis and therapy.

Authors:  Dale L Barnard
Journal:  Antiviral Res       Date:  2009-01-25       Impact factor: 5.970

4.  Bacterial pneumonia and pandemic influenza planning.

Authors:  Ravindra K Gupta; Robert George; Jonathan S Nguyen-Van-Tam
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

5.  Dual role for B-1a cells in immunity to influenza virus infection.

Authors:  Youn Soo Choi; Nicole Baumgarth
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.